Demystifying Drug Dosing in Renal Dysfunction

Chronic kidney disease affects approximately 10% of adults in the United States or approximately 20 million individuals. Further, recent studies have shown that improper dosing in patients with renal dysfunction occurs over 20% of the time. ASHP’s Demystifying Drug Dosing in Renal Dysfunction addresses the persistent and challenging problem of dosing medications for patients with renal insufficiency and dysfunction.

About the Author

Branden D. Nemecek, PharmD, BCPS is an Associate Professor of Pharmacy Practice at the Duquesne University School of Pharmacy and a Clinical Pharmacy Specialist practicing in internal medicine and nephrology at UPMC Mercy Hospital. Dr. Nemecek has been a clinician and faculty at Duquesne since completing his PGY2 internal medicine residency at the Medical University of South Carolina in 2013. He was recently named Director of Residency Programs for all Duquesne residency programs while serving as the program director for the PGY2 internal medicine program in association with Mercy Hospital. Nemecek is active on a national level with both ASHP and ACCP. He also serves as Chair of the International Pharmacy Education Committee at Duquesne. Drayton A. Hammond, PharmD, MBA, BCPS, BCCCP is Clinical Pharmacy Specialist at Rush University Medical Center in Chicago, IL. Previously, he served as Assistant Professor of Pharmacy Practice at University of Arkansas for Medical Sciences. He completed a PGY2 critical care residency at University of Florida Jacksonville Healthcare, Inc. and a PGY1 residency in pharmacy practice. He earned his PharmD at the Medical University of South Carolina and his MBA at The Citadel.